Soling Industrlal(002766)
Search documents
股海导航_2026年1月28日_沪深股市公告与交易提示
Xin Lang Cai Jing· 2026-01-27 23:14
Group 1 - Heng Rui Medicine's HRS-5346 tablets have been included in the list of breakthrough therapeutic varieties by the National Medical Products Administration, with a total R&D investment of approximately 76.3 million yuan [30][30] - Yuguang Jin Lead announced a significant short-term stock price increase of 45.01% over five consecutive trading days, raising concerns about the uncertainty of future silver prices [31] - Dongcai Technology's actual controller and vice chairman has been detained and investigated, but the company states that this will not significantly impact its normal operations [32] Group 2 - Aisen Co. plans to invest 2 billion yuan to establish an integrated circuit materials manufacturing base in East China, with the first phase expected to be operational by 2028 [33] - Jingpin Special Equipment has been banned from participating in procurement activities for the armed police force for three years, which will have a limited impact on its overall revenue [34] - Nanhua Futures' overseas subsidiary has obtained membership approval for the Nodal Exchange, allowing it to trade and clear related products [35] Group 3 - Zhong Rare Earth expects a net profit of 100 million to 130 million yuan in 2025, reversing a loss of 299 million yuan in the previous year due to market recovery and operational improvements [38] - Deep South Circuit anticipates a net profit increase of 68% to 78% in 2025, driven by growth in AI computing power and storage market demand [39] - Hai Xin Energy Science and Technology expects a net loss of 450 million to 640 million yuan in 2025, although this is an improvement from a loss of 954 million yuan the previous year [40] Group 4 - Nanya New Materials forecasts a net profit increase of 337% to 417% in 2025, attributed to the recovery in the copper-clad laminate industry [41] - CanSino Biologics expects a net profit of 24.5 million to 29 million yuan in 2025, driven by the growth of its quadrivalent meningococcal vaccine [42] - Zhiguang Electric anticipates a net profit of 110 million to 160 million yuan in 2025, reversing a loss of 326 million yuan due to rapid growth in its energy storage business [43] Group 5 - Dongfang Securities expects a net profit increase of 67.8% in 2025, supported by growth in its core investment banking and wealth management businesses [44] - King Long Motors forecasts a net profit of approximately 463.26 million yuan in 2025, reflecting a 193.68% increase due to steady growth in overseas markets [45] - Zhenray Technology expects a net profit increase of 529.64% to 642.26% in 2025, driven by demand in special integrated circuits and satellite communication markets [46] Group 6 - Yongding Co. anticipates a net profit of 200 million to 300 million yuan in 2025, representing an increase of 225.66% to 388.48% due to investment income from its joint ventures [47] - Xiamen Tungsten's preliminary report indicates a net profit of 2.311 billion yuan in 2025, a 35.08% increase driven by rising prices of tungsten and rare earth materials [48] - Guodun Quantum expects to achieve a net profit of around 5 million yuan in 2025, reversing a loss from the previous year due to growth in the quantum computing sector [49] Group 7 - Shijia Photon anticipates a net profit of approximately 342 million yuan in 2025, reflecting a growth of around 426% due to increased orders in optical chips and cables [50] - Ningbo Fubang expects a net profit of 50 million to 70 million yuan in 2025, with a significant increase of 3099.59% to 4379.43% driven by rising silver prices and non-recurring gains [51] - Huasheng Lithium Battery plans to adjust its share repurchase price limit from 32 yuan to 150 yuan per share, reflecting confidence in its future development [52]
1月27日增减持汇总:东方雨虹等8家公司拟减持 片仔癀增持(表)





Xin Lang Cai Jing· 2026-01-27 13:17
新浪声明:此消息系转载自新浪合作媒体,新浪网登载此文出于传递更多信息之目的,并不意味着赞同 其观点或证实其描述。文章内容仅供参考,不构成投资建议。投资者据此操作,风险自担。 | | | 1月27日上市公司盘后增持情况 | | --- | --- | --- | | 1 | 片仔癢 | 控股股东九龙江集团拟3亿元-5亿元增持公司股份 | | | | 1月27日上市公司盘后拟减持情况 | | 1 | 达意障 | 股东乐丰投资拟减持不超3%股份 | | 2 | 东方雨虹 | 控股股东李卫国拟减持不超3.00%股份 | | 3 | 视觉中国 | 实际控制人廖道训等拟合计减持不超过1.85%公司股份 | | 4 | 恒邦股份 | 股东恒邦集团及其一致行动人拟合计减持不超1%股份 | | 5 | 百达精工 | 股东杭州重湖拟合计减持不超2.00%股份 | | 6 | 傲农生物 | 股东拟合计减持不超1%股份 | | 7 | 复洁科技 | 实际控制人及其一致行动人拟减持不超过1% | | 8 | 索姜股份 | 股东高新投集团拟减持不超3%股份 | | | | 1月27日上市公司盘后增持情况 | | --- | --- | ...
索菱股份(002766.SZ):高新投集团拟减持不超过3%股份
Ge Long Hui A P P· 2026-01-27 10:24
格隆汇1月27日丨索菱股份(002766.SZ)公布,股东深圳市高新投集团有限公司(简称"高新投集团")计 划在本公告披露之日起15个交易日后的3个月内(即2026年2月26日至2026年5月25日)通过大宗交易和 集中竞价相结合的交易方式减持公司股份不超过25,916,769股(即不超过公司总股本的3%)。 ...
晚间公告|1月27日这些公告有看头
Di Yi Cai Jing· 2026-01-27 10:23
Group 1 - Heng Rui Medicine's HRS-5346 tablet has been included in the list of breakthrough therapeutic varieties by the National Medical Products Administration, with a total R&D investment of approximately 76.3 million yuan [2] - Yu Guang Jin Lead announced a significant stock price increase of 45.01% over five trading days, expressing uncertainty about the future price of silver [3] - Dongcai Technology's actual controller and vice chairman has been detained for investigation, but the company states that this will not significantly impact its normal operations [4] Group 2 - Aisen Co. plans to invest 2 billion yuan to establish an integrated circuit materials manufacturing base in East China, with the first phase expected to be operational by 2028 [5] - Jingpin Special Equipment has been banned from participating in procurement activities for three years, but the impact on overall operations is considered limited [6] - Nanhua Futures' overseas subsidiary has obtained membership at the Nodal Exchange, allowing it to trade and clear related products [7] Group 3 - Di'er Laser is planning to issue H-shares and apply for listing on the Hong Kong Stock Exchange to enhance its international strategy [8] - Zhong Rare Earth expects a net profit of 100 million to 130 million yuan in 2025, reversing a loss from the previous year due to market improvements [10] - Shen Nan Circuit anticipates a net profit increase of 68% to 78% in 2025, driven by demand in AI computing and smart automotive sectors [11] Group 4 - Hai Xin Energy Science and Technology expects a net loss of 450 million to 640 million yuan in 2025, although this is an improvement from the previous year's loss [12] - Nan Ya New Materials forecasts a net profit increase of 337% to 417% in 2025, attributed to a recovery in the copper-clad laminate industry [13] - CanSino expects a net profit of 24.5 million to 29 million yuan in 2025, driven by the growth of its quadrivalent meningococcal vaccine [14] Group 5 - Zhi Guang Electric anticipates a net profit of 110 million to 160 million yuan in 2025, reversing a previous loss due to growth in its energy storage business [15] - Dongfang Securities expects a net profit increase of 67.8% in 2025, benefiting from capital market opportunities [17] - Jinlong Automobile forecasts a net profit increase of 193.68% in 2025, supported by growth in overseas markets [18] Group 6 - Zhen Lei Technology expects a net profit increase of 529.64% to 642.26% in 2025, driven by demand in special integrated circuits [19] - Yong Ding Co. anticipates a net profit of 200 million to 300 million yuan in 2025, reflecting significant growth from investment income [20] - Xiamen Tungsten's preliminary report indicates a net profit of 2.311 billion yuan in 2025, a 35.08% increase year-on-year [21] Group 7 - Guo Dun Quantum expects a net profit of 5 million yuan in 2025, marking a return to profitability [22] - Shi Jia Photon forecasts a net profit increase of approximately 426% in 2025, driven by growth in optical chip orders [23] - Ningbo Fubang anticipates a net profit increase of 3099.59% to 4379.43% in 2025, largely due to rising silver prices and significant non-recurring gains [24] Group 8 - Huasheng Lithium Battery plans to adjust its share repurchase price limit from 32 yuan to 150 yuan per share [26] - Aonong Biological announced plans for multiple shareholders to reduce their stakes [28] - Pizaihuang's controlling shareholder intends to increase its stake by 300 million to 500 million yuan [29]
索菱股份:深圳市高新投集团有限公司拟减持不超3%股份
Mei Ri Jing Ji Xin Wen· 2026-01-27 09:31
每经AI快讯,1月27日,索菱股份公告,股东深圳市高新投集团有限公司,计划自2026年2月26日至 2026年5月25日通过大宗交易和集中竞价相结合的方式减持公司股份不超过2591.68万股(即不超过公司 总股本的3%)。 ...
索菱股份:深圳市高新投集团有限公司计划减持公司股份不超过约2592万股
Sou Hu Cai Jing· 2026-01-27 09:29
每经AI快讯,索菱股份1月27日晚间发布公告称,持有深圳市索菱实业股份有限公司股份约7657万股 (占公司总股本的比例为8.86%)的股东深圳市高新投集团有限公司,计划在本公告披露之日起15个交 易日后的3个月内(即2026年2月26日至2026年5月25日),通过大宗交易和集中竞价相结合的交易方式 减持公司股份不超过约2592万股。 每经头条(nbdtoutiao)——国际金价冲破5000美元!7年涨了280%,什么时候才见顶?专家:关键还 看美元,重点关注国际货币体系、降息和科技革命 (记者 曾健辉) 每日经济新闻 免责声明:本文内容与数据仅供参考,不构成投资建议,使用前请核实。据此操作,风险自担。 ...
索菱股份:高新投集团拟减持公司不超3%股份
Zheng Quan Shi Bao Wang· 2026-01-27 09:27
人民财讯1月27日电,索菱股份(002766)1月27日公告,公司持股8.86%的股东高新投集团计划通过大 宗交易和集中竞价相结合的交易方式,减持公司股份不超过2591.68万股(占公司总股本的3%)。 ...
索菱股份(002766) - 关于持股5%以上股东减持计划的预披露公告
2026-01-27 09:15
深圳市索菱实业股份有限公司 关于持股 5%以上股东减持计划的预披露公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有 虚假记载、误导性陈述或重大遗漏。 特别提示: 持有深圳市索菱实业股份有限公司(以下简称"公司"或"索菱股份")股份 76,566,957 股(占公司总股本的比例为 8.86%)的股东深圳市高新投集团有限公 司(以下简称"高新投集团")计划在本公告披露之日起 15 个交易日后的 3 个月 内(即 2026 年 2 月 26 日至 2026 年 5 月 25 日)通过大宗交易和集中竞价相结合 的交易方式减持公司股份不超过 25,916,769 股(即不超过公司总股本的 3%)。 公司于近日收到公司持股 5%以上股东深圳市高新投集团有限公司出具的关 于减持计划的《告知函》,现将相关情况公告如下: 一、股东基本情况 1、股东名称:深圳市高新投集团有限公司 证券代码:002766 证券简称:索菱股份 公告编号:2026-006 5、拟减持数量及比例:计划减持公司股份不超过 25,916,769 股(三个月内 通过证券交易所集中竞价交易减持股份的总数不得超过公司股份总数的 1%;三 个月 ...
索菱股份(002766) - 关于公司股票交易异常波动的公告
2026-01-20 11:02
深圳市索菱实业股份有限公司 关于公司股票交易异常波动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有 虚假记载、误导性陈述或重大遗漏。 一、股票交易异常波动的情况介绍 深圳市索菱实业股份有限公司(以下简称"公司")股票(证券简称:索菱股 份,证券代码:002766)于 2026 年 1 月 16 日、2026 年 1 月 19 日、2026 年 1 月 20 日连续三个交易日收盘价格跌幅偏离值累计达到 20%以上,根据《深圳证 券交易所交易规则》的有关规定,属于股票交易异常波动的情况。 二、公司关注、核实的情况说明 针对公司股票交易异常波动,公司通过电话沟通、问询等方式向公司管理层、 控股股东对有关事项进行了核查,现将核实情况说明如下: 1、前期披露的信息不存在需要更正、补充之处; 2、未发现近期公共传媒报道了可能或已经对公司股票交易价格产生较大影 响的未公开重大信息; 证券代码:002766 证券简称:索菱股份 公告编号:2026-005 特此公告! 深圳市索菱实业股份有限公司 董事会 3、公司已披露的经营情况、内外部经营环境未发生重大变化; 4、公司控股股东中山乐兴企业管理咨询有限公 ...
索菱股份:股票交易异常波动,2025年预亏5000万至7000万元
Xin Lang Cai Jing· 2026-01-20 10:59
Core Viewpoint - The company announced that its stock experienced significant price fluctuations over three consecutive trading days, indicating abnormal volatility, but no major undisclosed information was found and the operating environment remains unchanged [1] Financial Performance - For the fiscal year 2025, the company expects a net profit loss ranging from 70 million to 50 million yuan, with a non-recurring loss estimated between 78.5 million and 58.5 million yuan [1] Shareholder Activity - The controlling shareholder's concerted action partner, Tanghe Holdings, has successfully completed the transfer of 37.5 million shares [1] Risk Advisory - The company has reminded investors to be cautious regarding potential risks, although no significant undisclosed matters are currently present [1]